What caused the MDCE stock jump on 11 Mar 2026?

The surge reflected speculative buying and a large volume spike of 269,674,402 shares versus average 22,273,408. There were no formal MDCE earnings releases; the move ties to trading flows and peer comparisons rather than fresh company fundamentals.

What is Meyka AI's current grade for MDCE stock?

Meyka AI gives MDCE a score of 61.40 out of 100, Grade B with a HOLD suggestion. The grade factors S&P and sector comparisons, growth metrics, key ratios, and analyst signals.

What price target and risk scenarios apply to MDCE stock?

Meyka AI's short-term model target is $0.0010 USD (about +150.00% from $0.0004). A downside scenario to $0.0002 USD implies -50.00%. Forecasts are model-based and not guarantees.

Is MDCE a liquid investment for large portfolios?

No. MDCE is low-priced OTC microcap with wide spreads, high slippage risk, and a relatively small market cap of about 1,289,601 USD. Large orders can move the market and face execution challenges.

US Stocks

+33% surge for MDCE Medical Care Technologies (PNK) Mar 2026: check liquidity

ByDanny Kontos March 12, 2026March 12, 2026

MDCE stock jumped 33.33% to $0.0004 during market hours on 11 Mar 2026 on a heavy volume spike. The move came with 269,674,402 shares traded versus an average of 22,273,408, signaling speculative interest and short-term liquidity shifts. Medical Care Technologies (MDCE) trades on the PNK exchange in the United States (USD) market and remains a microcap, low-price name that moves sharply on flow rather than fundamentals. Investors should treat intraday swings as high-risk signals and weigh liquidity before taking positions.